Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase
- PMID: 12794750
- DOI: 10.1002/ijc.11178
Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase
Abstract
Nitric oxide (NO) and its metabolites are implicated in carcinogenesis and metastasis. Both stimulatory and inhibitory effects of NO have been reported in relation to breast cancer and its role in the development of malignancies and metastasis remains uncertain. We have used the polyomavirus middle T antigen (PyV-mT) targeted to the mouse mammary gland and bred into an inducible NO synthase (iNOS)-deficient C57Bl/6 strain to examine a role for nitric oxide in modulating tumors that develop in the complex environment of the whole animal. The development of hyperplasias was delayed to the extent that the earliest palpable tumors arose 2-4 weeks later in PyV-mT/iNOS(-/-) mice compared with PyV-mT/iNOS(+/+) mice, identifying a role for iNOS in early events in mammary tumor formation. Tumors that did develop in PyV-mT/iNOS(-/-) mice were characteristically well differentiated and had a cribriform pattern. Other tumors were myoepithelial adenocarcinomas with uniform nuclear size. In contrast, mice capable of iNOS activity typically developed solid nodular adenocarcinomas with a high mitotic index and pleomorphic nuclei. No significant effect of iNOS deficiency was found on vascular density in hyperplasias or tumors by examining CD31-positive vessels. The infiltration of lesions by macrophages, cells capable of significant NO production, remained unchanged in PyV-mT/iNOS(-/-) mice. Metastatic potential was retained by PyV-mT-transformed epithelium in the absence of iNOS, indicating that NO production by iNOS is not essential for this process. These results indicate a role for iNOS in tumorigenesis, particularly in the regulation of early events.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.Arch Oral Biol. 2003 Jun;48(6):415-22. doi: 10.1016/s0003-9969(03)00085-2. Arch Oral Biol. 2003. PMID: 12749913
-
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.Mol Cancer Ther. 2004 Aug;3(8):941-53. Mol Cancer Ther. 2004. PMID: 15299077
-
Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.Breast Cancer Res. 2014 Jan 23;16(1):R11. doi: 10.1186/bcr3603. Breast Cancer Res. 2014. PMID: 24457046 Free PMC article.
-
Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin.Semin Cancer Biol. 2005 Aug;15(4):277-89. doi: 10.1016/j.semcancer.2005.04.004. Semin Cancer Biol. 2005. PMID: 15914026 Review.
-
Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.Cancer Metastasis Rev. 1998 Mar;17(1):55-75. doi: 10.1023/a:1005956721457. Cancer Metastasis Rev. 1998. PMID: 9544423 Review.
Cited by
-
Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells.BMC Cancer. 2015 Jan 15;15:4. doi: 10.1186/s12885-015-1005-7. BMC Cancer. 2015. PMID: 25588705 Free PMC article.
-
History of myeloid-derived suppressor cells.Nat Rev Cancer. 2013 Oct;13(10):739-52. doi: 10.1038/nrc3581. Nat Rev Cancer. 2013. PMID: 24060865 Free PMC article. Review.
-
Chronic Exposure to Low Levels of Parabens Increases Mammary Cancer Growth and Metastasis in Mice.Endocrinology. 2023 Jan 9;164(3):bqad007. doi: 10.1210/endocr/bqad007. Endocrinology. 2023. PMID: 36683225 Free PMC article.
-
Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8894-9. doi: 10.1073/pnas.0400453101. Epub 2004 Jun 3. Proc Natl Acad Sci U S A. 2004. PMID: 15178764 Free PMC article.
-
NO to breast: when, why and why not?Curr Pharm Des. 2010;16(4):451-62. doi: 10.2174/138161210790232130. Curr Pharm Des. 2010. PMID: 20236074 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases